icon-    folder.gif   Conference Reports for NATAP  
 
  Back grey_arrow_rt.gif
 
 
 
 
 
Lenacapavir (GS-6207) Sustained Delivery Formulation Supports 6-Month Dosing Interval
 
 
  IAC 2020 Virtual July 6-10
Reported by Jules Levin
 
Rebecca Begley, Justin Lutz, Martin Rhee, Hadas Dvory-Sobol, Anna Chiu, Steve K. West,
Jessica Corpus, John Ling, Polina German
Gilead Sciences, Inc., Foster City, California, USA

0708201

0708202

0708203

0708204

0708205

0708206